Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 10,369,161

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,369,161

Title:	Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
Abstract:	Disclosed are methods of administering 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to treat primary hyperparathyroidism and/or to treat and/or prevent the symptoms of primary hyperparathyroidism in as subject having or at risk for developing primary hyperparathyroidism, preferably without inducing hypercalcemia in the patient.
Inventor(s):	DeLuca; Hector F. (Deerfield, WI), Plum; Lori A. (Arena, WI), Clagett-Dame; Margaret (Deerfield, WI)
Assignee:	Wisconsin Alumni Research Foundation (Madison, WI)
Application Number:	14/710,744
Patent Claims:	see list of patent claims

Details for Patent 10,369,161

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	Wisconsin Alumni Research Foundation (Madison, WI)	2034-12-30	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	002	2015-01-23	➤ Sign Up	Wisconsin Alumni Research Foundation (Madison, WI)	2034-12-30	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	003	2015-01-23	➤ Sign Up	Wisconsin Alumni Research Foundation (Madison, WI)	2034-12-30	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	004	2015-01-23	➤ Sign Up	Wisconsin Alumni Research Foundation (Madison, WI)	2034-12-30	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,369,161

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
Australia	2015374467	Jun 15, 2017
Canada	2969335	Jul 07, 2016
European Patent Office	3240548	Nov 08, 2017
Japan	2018500373	Jan 11, 2018
United States of America	2016184327	Jun 30, 2016
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.